blogTO9d
Historic Ontario farm with gothic farmhouse is on sale for $10 million
The Smith family moved from Scotland to Caledon, Ontario and started buying up swathes of land.  The family were prominent in ...
BioSpace15d
Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases, today ...
Finanznachrichten15d
Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases ...
Nasdaq15d
Quoin Stock Surges On Positive Interim Results For QRX003 In Pediatric Netherton Syndrome
(RTTNews) - Quoin Pharmaceuticals, Ltd. (QNRX) Tuesday announced positive interim clinical data from its ongoing Investigator Pediatric Netherton Syndrome clinical study using QRX003. The data ...
Stockhouse15d
Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company ...
Morningstar15d
Quoin Pharmaceuticals Announces Further Positive Clinical Data from Ongoing Pediatric Netherton Syndrome Study
Jan. 14, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage, specialty pharmaceutical company focused on rare and orphan ...
Investing16d
Quoin reports progress in pediatric skin disorder study
ASHBURN, Va. - Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX), a clinical-stage specialty pharmaceutical company with a market capitalization of $2.89 million, announced positive interim clinical data ...
ETF Daily News1mon
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX) CFO Gordon Dunn Buys 122,221 Shares of Stock
10 Stocks to Sell NOW! 3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Quoin Pharmaceuticals, Ltd., a clinical stage specialty pharmaceutical ...
ArchDaily1mon
Brick: The Latest Architecture and News
Positioned on the sun-facing side of a structure, it consists of a wall made from materials like brick, stone, or concrete, and a glass panel or polycarbonate sheet placed a few centimeters in ...
Finanznachrichten1mon
Quoin Pharmaceuticals, Inc.: Quoin Pharmaceuticals Announces FDA Clearance to Initiate New QRX003 Netherton Syndrome Clinical Study
Dec. 19, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a clinical stage, specialty pharmaceutical company focused on rare and orphan diseases ...
Business Insider1mon
Quoin Pharmaceuticals Annual Meeting Approves Key Amendments
Pick the best stocks and maximize your portfolio: Quoin Pharmaceuticals ( (QNRX)) has shared an update. Quoin Pharmaceuticals Ltd. held its 2024 Annual General Meeting where shareholders approved ...